• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

SANUWAVE Health Inc.

Sanuwave completes Celarity buy

August 13, 2020 By Sean Whooley

Sanuwave Health (OTC:SNWV) announced that it completed its acquisition of Celularity’s UltraMist ultrasound healing therapy platform. In June, the companies announced an exclusive agreement for the purchase, which includes exclusive partnership rights for Celularity’s wound care biologic products. Celularity develops allogeneic cellular therapies engineered from postpartum human placenta, in cancer, infectious disease and degenerative disease. Along with the […]

Filed Under: Business/Financial News, Imaging, Mergers & Acquisitions, Ultrasound, Wall Street Beat, Wound Care Tagged With: Celularity, Sanuwave, SANUWAVE Health Inc.

Sanuwave announces intent to acquire Celularity’s UltraMist

June 11, 2020 By Sean Whooley

Sanuwave Health (OTC:SNWV) announced that it entered into an exclusive agreement to acquire Celularity’s UltraMist ultrasound healing therapy platform. The non-binding letter of intent includes the acquisition of UltraMist and exclusive partnership rights for Celularity’s wound care biologic products, according to a news release. Celularity develops allogeneic cellular therapies engineered from postpartum human placenta, in cancer, […]

Filed Under: Business/Financial News, Mergers & Acquisitions, Ultrasound, Wound Care Tagged With: Celularity, Sanuwave, SANUWAVE Health Inc.

Sanuwave partners with The Mobile Health Company

May 19, 2020 By Sean Whooley

Sanuwave Health announced that it is partnering with its former president’s new business, The Mobile Health Company (MHC). Former Sanuwave president Shri Parikh launched MHC as a mobile solution for wound care and other treatments to be streamlined directly to a patient’s home setting. In launching MHC, Shri is resigning from Sanuwave, but will remain […]

Filed Under: Business/Financial News, Wound Care Tagged With: Mobile Health Company, Sanuwave, SANUWAVE Health Inc.

Sanuwave Health, HyperMed partner for DermaPace diabetic foot ulcer study

July 12, 2018 By Fink Densford

Sanuwave Health (OTC:SNWV) said yesterday it is partnering with HyperMed to sponsor a clinical investigation exploring Sanuwave’s DermaPace system designed for treating diabetic foot ulcers. The joint study will look to quantify the level of increased perfusion and oxygenation during and after treatment with the DermaPace, Suwanee, Ga.-based Sanuwave said. The study will use HyperMed’s Hyperview […]

Filed Under: Business/Financial News, Clinical Trials, Regenerative Medicine, Wound Care Tagged With: SANUWAVE Health Inc.

7 medtech stories we missed this week: July 21, 2017

July 21, 2017 By Danielle Kirsh

From Second Sight’s South Korean market entry to Sanuwave’s Indonesian distribution deal, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Second Sight enters South Korea market Second Sight announced in a July 5 press release that it has entered the market in South Korea with the implantation […]

Filed Under: 510(k), Business/Financial News, Clinical Trials, Food & Drug Administration (FDA), Implants, Regenerative Medicine, Regulatory/Compliance, Robotics, Spine, Surgical Tagged With: Alpha Tau Medical, Apifix, Hillrom, K2M, Mitsubishi, Reha Technology, SANUWAVE Health Inc., Second Sight

Sanuwave Health inks dev deal with eKare for wound care integration

June 8, 2017 By Fink Densford

Sanuwave Health (OTC:SNWV) said today it entered a memorandum of understanding with eKare to develop novel wound care analysis and management solutions which integrates technology from both companies. Through the deal, Sanuwave’s dermaPace wound treatment device will be linked with eKare’s inSight 3D wound imaging and analytics system to produce a comprehensive wound management solution, […]

Filed Under: Business/Financial News, Research & Development, Wound Care Tagged With: ekare, SANUWAVE Health Inc.

Sanuwave Health taps Lithomed as Taiwanese ortho distributor

May 25, 2017 By Fink Densford

Sanuwave Health (OTC:SNWV) said today it tapped Lithomed as its orthopedic product distributor in Taiwan. Suwanee, Ga.-based Sanuwave said the selection of Lithomed was the result of an extensive search in the region, and that the contract comes with a minimum order value of $500,000. “Sanuwave has committed to deliver 3-5 new distribution partners in the second […]

Filed Under: Distribution, Orthopedics Tagged With: SANUWAVE Health Inc.

Teleflex CEO Smith to step down | Personnel Moves | March 1, 2017

March 1, 2017 By Brad Perriello

Teleflex (NYSE:TFX) said this month that CEO Benson Smith will retire from the corner office by the end of this calendar year. Smith will continue to serve as the company’s chairman of the board. Liam Kelly, president & chief operating officer, was tapped to succeed Smith as CEO for the Wayne, Pa.-based company. “I want to […]

Filed Under: Business/Financial News Tagged With: Active Implants, Delcath Systems Inc., Glaukos, medical-metrics, Medizone, nda-partners, Novo Nordisk, Personnel Moves, SANUWAVE Health Inc., Teleflex, veracyte

Sanuwave files for de novo FDA nod for DermaPace wound care device

August 15, 2016 By Fink Densford

Sanuwave Health (OTC:SNWV) said last Thursday it filed a de novo petition with the FDA as it seeks approval for its DermaPace system designed for treating diabetic foot ulcers. Sanuwave said it expects to hear a response from the FDA within 120 days, and is hopeful that evidence from over 336 patients across 2 trials are enough […]

Filed Under: Diabetes, Food & Drug Administration (FDA) Tagged With: SANUWAVE Health Inc.

Sanuwave trial misses efficacy endpoint but shows superiority at 24 weeks

March 24, 2016 By Fink Densford

Sanuwave Health (OTC:SNWV) today released 24-week data from the pivotal trial of its dermaPace, saying it missed its 12-week primary efficacy endpoint but returned a greater reduction in wound size and lowered amounts of subjects with increased wound size compared to the control treatment at 24 weeks. Data came from 2 24-week studies at 39 centers across the […]

Filed Under: Clinical Trials, Diabetes, Regenerative Medicine Tagged With: SANUWAVE Health Inc.

Sanuwave Health brings in $1.5m for dermaPACE

March 22, 2016 By Fink Densford

Sanuwave Health (OTC:SNWV) said Monday it closed a $1.5 million round of equity financing to help support the FDA submission of Phase III clinical trial data to support the clearance of its dermaPACE device designed for treating diabetic foot ulcers. The company said it expects to close another round with an additional amount under the […]

Filed Under: Business/Financial News, Diabetes Tagged With: SANUWAVE Health Inc.

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS